Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ALEMBICLTD | NSE
-0.33
-0.22%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
17/09/2024
146.34
147.10
147.60
144.00
Alembic Limited engages in the manufacturing and marketing of fermentation and chemistry based active pharmaceuticals ingredients (API). It operates through API and Real Estate segments. The company is also involved in the construction of residential and commercial real estate projects; provision of project management and marketing consultancy services; and leasing of commercial properties. In addition it operates co-generation plants with a total capacity of 11 MW; and wind power plants with a total capacity of 5 MW. Alembic Limited was founded in 1907 and is based in Vadodara India. Alembic Limited is a subsidiary of Nirayu Limited.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Operating Margin (> 25%)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
Negative Momentum (Declining Price)
Price Below SMA10D
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
36.3%1 month
49.0%3 months
51.8%6 months
50.2%14.02
-
1.83
0.00
0.00
33.10
24.76
-
659.90M
37.58B
448.81M
1.54
35.25
25.40
37.80
12.60
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
22.75
Range1M
28.00
Range3M
68.75
Rel. volume
0.40
Price X volume
126.97M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Gufic Biosciences Limited | GUFICBIO | Drug Manufacturers-Specialty & Generic | 401 | 40.21B | -0.67% | 46.93 | 62.51% |
RPG Life Sciences Limited | RPGLIFE | Drug Manufacturers-Specialty & Generic | 2225.3 | 37.14B | -3.25% | 43.29 | 0.00% |
Indoco Remedies Limited | INDOCO | Drug Manufacturers-Specialty & Generic | 375.1 | 34.70B | 2.08% | 46.10 | 60.54% |
Suven Life Sciences Limited | SUVEN | Drug Manufacturers-Specialty & Generic | 157.11 | 34.26B | -4.59% | n/a | 0.26% |
SOLARA | SOLARA | Drug Manufacturers-Specialty & Generic | 742.95 | 32.02B | -2.19% | n/a | 107.90% |
IOL Chemicals and Pharmaceuticals Limited | IOLCP | Drug Manufacturers-Specialty & Generic | 492.25 | 28.90B | -3.50% | 25.17 | 2.03% |
Themis Medicare Limited | THEMISMED | Drug Manufacturers-Specialty & Generic | 275.25 | 25.38B | -1.56% | 49.52 | 25.36% |
Syncom Formulations (India) Limited | SYNCOMF | Drug Manufacturers-Specialty & Generic | 23.86 | 22.81B | -4.22% | 83.97 | 25.16% |
Amrutanjan Health Care Limited | AMRUTANJAN | Drug Manufacturers-Specialty & Generic | 779.25 | 22.51B | -0.87% | 53.49 | 0.60% |
Hester Biosciences Limited | HESTERBIO | Drug Manufacturers-Specialty & Generic | 2453.25 | 20.90B | 0.82% | 104.10 | 83.75% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
V2 Retail Limited | V2RETAIL | Apparel Retail | 1147.65 | 39.70B | 1.48% | 133.29 | 191.28% |
Vertoz Advertising Limited | VERTOZ | Advertising Agencies | 33.05 | 28.31B | -2.91% | 82.05 | 10.74% |
"SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 185.77 | 27.39B | 0.19% | 29.68 | 43.67% |
Signpost India Limited | SIGNPOST | Advertising Agencies | 227.83 | 23.44B | -0.81% | n/a | 80.30% |
Bhagyanagar India Ltd | BHAGYANGR | Copper | 109.13 | 3.49B | 4.60% | 34.15 | 52.08% |
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 169.14 | 1.88B | 5.00% | 49.20 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 98.53 | 1.41B | -0.47% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 37.62 | 1.05B | -0.11% | n/a | 32.70% |
Sagardeep Alloys Limited | SAGARDEEP | Copper | 28.04 | 481.85M | -0.85% | 88.75 | 43.14% |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 15.73 | 355.84M | -5.58% | n/a | 0.00% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 33.10 | - | Expensive |
Ent. to Revenue | 24.76 | - | Expensive |
PE Ratio | 14.02 | 47.84 | Cheaper |
Price to Book | 1.83 | 6.55 | Cheaper |
Dividend Yield | 1.54 | - | Leader |
Std. Deviation (3M) | 51.81 | - | Riskier |
Debt to Equity | 0.00 | 0.34 | Cheaper |
Debt to Assets | 0.00 | 0.17 | Cheaper |
Market Cap | 37.58B | - | Emerging |